Product introduction

Lenvatinib Capsule is used to treat certain types of cancers like differentiated thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It works by blocking specific proteins that promote cancer cell growth and spread, and reducing tumor size in affected individuals.

Lenvatinib Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will determine the right dose and how often you should take it. This will depend on what you are being treated for. The dosage may change over time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects.

Common side effects of this medicine include high blood pressure, bleeding, and diarrhea. It might also cause severe headaches and loss of appetite. If any of these side effects persist or worsen, consult your doctor. They may be able to suggest ways to manage the side effects.

Before taking Lenvatinib Capsule, tell your doctor if you have heart disease, liver, or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect or be affected by this medicine, so let your doctor know about all the medicines you are taking. Pregnant and breastfeeding women should consult their doctors before starting this medicine, as it may cause harm to the developing baby.

Uses of Lenvatinib Capsule

Differentiated Thyroid cancer
Treatment of Kidney cancer
Liver cancer
Treatment of Endometrial cancer

Benefits of Lenvatinib Capsule

In Differentiated Thyroid cancer

Thyroid is a butterfly-shaped gland located at the base of your neck. Your thyroid produces hormones that regulate your heart rate, blood pressure, body temperature and weight. Thyroid cancer occurs in the cells of the thyroid and it might not cause any symptoms at first. Lenvatinib Capsule restricts the oxygen supply of the cancer cells and stops its growth as well as further spread. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

Side effects of Lenvatinib Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Lenvatinib

High blood pressure
Diarrhea
Increased bleeding tendency

How to use Lenvatinib Capsule

Take this medicine in the dose and duration as advised by your doctor. Lenvatinib Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Lenvatinib Capsule works

Lenvatinib Capsule is a tyrosine kinase inhibitor. It works by blocking the oxygen and nutrient supply to cancer cells, due to which they stop growing. And Lenvatinib Capsule helps in treating thyroid cancer.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Lenvatinib Capsule. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Lenvatinib Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Lenvatinib Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

CONSULT YOUR DOCTOR

It is not known whether Lenvatinib Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

CAUTION

Lenvatinib Capsule should be used with caution in patients with kidney disease. Dose adjustment of Lenvatinib Capsule may be needed. Please consult your doctor.

Liver

CAUTION

Lenvatinib Capsule should be used with caution in patients with liver disease. Dose adjustment of Lenvatinib Capsule may be needed. Please consult your doctor.

What if you forget to take Lenvatinib Capsule?

If you miss a dose of Lenvatinib Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Quick tips

Take it with or without food, preferably at the same time each day.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure, such as severe headache, confusion, problems with your eyesight, nausea, or vomiting.
It may cause serious bleeding problems. Inform your doctor if you get headaches or stomach pain or if you notice blood in your urine or stools.
Consult your doctor if you are pregnant, planning to conceive, or breastfeeding.

FAQs

How will I know if Lenvatinib Capsule is working?

To evaluate if Lenvatinib Capsule is effective, your doctor may assess your improvement through scans to monitor your tumor. Your doctor can let you know how well you are doing with Lenvatinib Capsule treatment and if there is any resolution of your tumor.

What are the most serious side effects of Lenvatinib Capsule I should watch out for?

During Lenvatinib Capsule treatment, contact your doctor or go to the hospital immediately if you experience serious side effects. These may include high blood pressure, such as severe headaches or chest pain. You may also have heart problems like shortness of breath, swelling, or a fast heartbeat. Bleeding or blood in vomit or stool can occur. Signs of liver or kidney failure include yellowing of the skin, confusion, or dark urine. Other serious symptoms may include severe diarrhea or vomiting, seizures, vision changes, or confusion. These could be signs of posterior reversible encephalopathy syndrome (PRES), a rare brain condition.

Can I stop taking Lenvatinib Capsule if my symptoms have improved?

No, never stop taking Lenvatinib Capsule on your own, as doing this may cause your cancer to worsen or spread to other parts of the body. Stopping abruptly without your doctor’s advice may cause serious harm to your body.

Who should avoid taking Lenvatinib Capsule?

You should avoid taking Lenvatinib Capsule if you are allergic to lenvatinib or any of its ingredients. Do not take it if you have uncontrolled high blood pressure, have had recent major surgery (as it may delay wound healing), have a hole in the stomach or intestine, or have recently had a stroke or heart attack. Always inform your doctor about your complete medical history before starting Lenvatinib Capsule treatment to ensure safer, better, and faster results.

Will I need regular check-ups or tests while taking Lenvatinib Capsule?

Yes, your doctor will check blood pressure, liver function, kidney function, thyroid function, calcium level, protein in urine, heart function (possibly with ECGs), etc. These tests help catch serious problems early.

How long do I have to continue taking Lenvatinib Capsule?

You should continue the Lenvatinib Capsule treatment until cancer has not properly resolved. Stopping or modification in the dose should only be done by a doctor once your cancer has resolved and shows no active symptoms.

Does Lenvatinib Capsule affect my fertility?

Lenvatinib Capsule may impair fertility. Talk to your doctor about options like egg preservation before starting treatment.

What other precautions should I take during Lenvatinib Capsule treatment?

While on Lenvatinib Capsule treatment, you should not have surgery unless your doctor tells you to stop the medicine as it can slow healing, tell your dentist before any dental work (it can increase the risk of jaw problems), and drink plenty of fluids to avoid dehydration, especially if you have diarrhea.

TRUSTED Anti Cancer MEDICINE PROVIDER – UNNATI PHARMAX

References:-

European Medicines Agency (EMA)

Lenvima (Lenvatinib) – EPAR (European Public Assessment Report)
Official dossier covering indications (differentiated thyroid carcinoma, hepatocellular carcinoma, and endometrial carcinoma in combination), mechanism of action, safety data, dosing, and more.
https://www.ema.europa.eu/en/medicines/human/EPAR/lenvima European Medicines Agency (EMA)
Kisplyx (Lenvatinib) – EPAR
Regulatory assessment for Lenvatinib when used in combination therapies for advanced renal cell carcinoma (e.g., with everolimus or pembrolizumab), including dosage and administration guidelines.
https://www.ema.europa.eu/en/medicines/human/EPAR/kisplyx European Medicines Agency (EMA)
EMA Paediatric Investigation Plans (PIP)
Modifications and status of pediatric study requirements for Lenvima/Kisplyx in various cancers.
- Decision on PIP modification: https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001119-pip03-19-m03 European Medicines Agency (EMA)
- Decision on PIP modification for additional indications: https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001119-pip02-12-m08 European Medicines Agency (EMA)

U.S. FDA

FDA Approval – Lenvatinib for Unresectable Hepatocellular Carcinoma (Lenvima Capsules)
U.S. FDA approval announcement for Lenvatinib capsules in this indication, based on the REFLECT trial outcomes.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lenvatinib-unresectable-hepatocellular-carcinoma U.S. Food and Drug Administration
FDA Approval – Lenvatinib + Everolimus for Advanced Renal Cell Carcinoma
Official announcement of FDA authorization for the combination therapy following prior VEGF-targeted treatments.
https://www.fda.gov/drugs/resources-information-approved-drugs/lenvatinib-combination-everolimus U.S. Food and Drug Administration
FDA Approval – Lenvatinib + Pembrolizumab for Advanced RCC
Details official approval for the first-line combination treatment in advanced renal cell carcinoma.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lenvatinib-plus-pembrolizumab-advanced-renal-cell-carcinoma U.S. Food and Drug Administration
FDA Approval – Pembrolizumab + Lenvatinib for Advanced Endometrial Carcinoma
Regulatory confirmation of this combination for advanced endometrial cancer not responsive to earlier treatments.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-pembrolizumab-and-lenvatinib-advanced-endometrial-carcinoma U.S. Food and Drug Administration
FDA Drug Trials Snapshot – Lenvima
Snapshot summarizing clinical trial demographics and efficacy outcomes that supported FDA approval for thyroid carcinoma.
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-lenvima U.S. Food and Drug Administration
FDA Drug Approval Package (Lenvima Capsules)
A comprehensive archive including approval letters, label PDFs, and detailed review documentation of the original approval.
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206947Orig1s000TOC.cfm

Reviews

There are no reviews yet.

Be the first to review “Lenvatinib Capsule”

Need help? WA us:

Lenvatinib Capsule

Have any Questions?

Product introduction

Uses of Lenvatinib Capsule